Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAX576 in seasonal allergic rhinitis
NCT00584584Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2007
- Primary completion
- Aug 2008
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of dectrekumab in seasonal allergic rhinitis (SAR), sponsored by Novartis. Started Dec 2007; status: completed.
02
Drugs
dectrekumab
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00584584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584584.